Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 3154-3160, October 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, D. L.
Right arrow Articles by Pearson, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, D. L.
Right arrow Articles by Pearson, J. W.

Isolation and Characterization of a Spontaneous Lymphocytic Leukemia (L-76) in the Strain 2 Guinea Pig1

David L. Klein2, Kalman Perk, John E. Dahlberg, Wayne Brown and John W. Pearson

Viral Immunotherapy Section, Laboratory of RNA Tumor Viruses, National Cancer Institute, Bethesda, Maryland 20014 [D. L. K., J. E. D., W. B., J. W. P.], and Hebrew University of Israel, Rehovat Campus, P. O. B. 12, Rehovat, Israel [K. P.]

A partial characterization of a transplantable guinea pig leukemia (L-76) that arose spontaneously in a young female strain 2 animal is described. The leukemia appears to be histologically, pathologically, and karyologically similar to the L2C lymphoblastic leukemia, which also arose spontaneously 24 years earlier. The presence of C3 receptor sites on the surface of the leukemia indicates it to be of B-cell origin. Although the L-76 leukemia originated in a strain 2 animal, it also produces a rapidly progressing, lymphoblastic leukemia in strain 13, Hartley, and strain 2 x strain 13 F1 hybrid adult guinea pigs. An inoculation of 2 x 105 blast cells obtained from peripheral blood induced a stem cell leukemia in the strain 2 host within 12 days, with white blood cell counts of 2 to 3 x 105 cells/cu mm at expiration. Titration data indicated that as few as 10 cells injected s.c. were capable of transmitting a systemic disease, which reached a terminal phase by 40 days. Pathological examination indicated involvement of the entire hematopoletic system, with almost all organs infiltrated by massive concentrations of neoplastic lymphoblasts. Treatment of the leukemia with Cytoxan (cyclophosphamide), 100 mg/kg, provided a remission period that lasted 4 to 5 weeks with eventual relapse and death due to the leukemia. Treatment of leukemic guinea pigs with 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MECCNU) alone or in combination with cyclophosphamide resulted in long-term survivors apparently "cured" of leukemia.

1 This work was supported by Contract NO1-CP-53566 within the Virus Cancer Program of the National Cancer Institute.

2 To whom requests for reprints should be addressed.

Received 1/30/78. Accepted 7/ 5/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.